Relationship between retinopathy and glycaemic control in insulin-dependent and non-insulin-dependent diabetes

Insights

Poor glycemic control, measured by glycosylated hemoglobin (HbA1), is linked to diabetic retinopathy in both insulin-dependent and non-insulin-dependent patients. Diabetes duration also independently predicts retinopathy.

Area of Science:

  • Endocrinology
  • Ophthalmology
  • Diabetology

Background:

  • Diabetic retinopathy is a leading cause of vision loss.
  • Glycemic control is crucial in managing diabetes complications.
  • The relationship between glycemic control and retinopathy requires further elucidation.

Purpose of the Study:

  • To investigate the association between antecedent glycemic control, assessed via serial glycosylated hemoglobin (HbA1) measurements, and the prevalence of diabetic retinopathy.
  • To examine this relationship in both insulin-dependent and non-insulin-dependent diabetic patients.
  • To assess the independent contributions of diabetes duration, hypertension, and smoking to retinopathy prevalence.

Main Methods:

  • Prospective study involving 40 insulin-dependent and 41 non-insulin-dependent diabetic patients.
  • Serial glycosylated hemoglobin (HbA1) measurements used to determine antecedent diabetic control.
  • Multiple logistic regression analysis employed to assess associations between variables and retinopathy prevalence.

Main Results:

  • A significant association was found between mean HbA1 levels and the prevalence of diabetic retinopathy in both patient groups.
  • Diabetes duration was also significantly associated with retinopathy prevalence, independent of glycemic control.
  • Hypertension and smoking did not emerge as significant independent risk factors for retinopathy in this cohort.

Conclusions:

  • Antecedent glycemic control, reflected by HbA1 levels, is a significant predictor of diabetic retinopathy.
  • Diabetes duration is an independent risk factor for retinopathy.
  • The findings underscore the importance of maintaining optimal glycemic control to prevent or delay diabetic retinopathy.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...